InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 13.65
-0.83 (-5.73%)
Sep 10, 2026, 11:59 AM HKT
InnoCare Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6,328 | 7,072 | 6,241 | 8,287 | 8,698 | 5,929 |
Short-Term Investments | 664.23 | - | - | - | - | - |
Trading Asset Securities | 900.06 | - | 759.18 | - | 313.29 | 317.06 |
Cash & Short-Term Investments | 7,892 | 7,072 | 7,000 | 8,287 | 9,011 | 6,246 |
Cash Growth | 11.85% | 1.03% | -15.53% | -8.04% | 44.28% | 57.34% |
Accounts Receivable | 550.42 | 502.88 | 351 | 276.38 | 127.83 | 45.27 |
Other Receivables | 0 | 0 | 0.05 | 31.34 | 61.79 | 62.27 |
Receivables | 550.43 | 502.88 | 351.05 | 307.71 | 189.61 | 107.55 |
Inventory | 198.53 | 162.87 | 95.58 | 119.09 | 65.32 | 9.92 |
Other Current Assets | 561.64 | 324.09 | 373.56 | 51.38 | 33.56 | 53.87 |
Total Current Assets | 9,203 | 8,062 | 7,820 | 8,765 | 9,300 | 6,417 |
Property, Plant & Equipment | 733.28 | 752.26 | 814.27 | 798.5 | 937.27 | 566.08 |
Long-Term Investments | 890.28 | 1,201 | 0.4 | 5.66 | 11.71 | 326.1 |
Goodwill | 3.12 | 3.12 | 3.12 | 3.12 | 3.13 | 3.13 |
Other Intangible Assets | 242.6 | 248.05 | 258.14 | 266.03 | 41.31 | 34.17 |
Long-Term Deferred Charges | 30.8 | 30.31 | 31.94 | 33.3 | - | - |
Other Long-Term Assets | 114.75 | 526.24 | 479.43 | 48.06 | 28.04 | 50.95 |
Total Assets | 11,218 | 10,824 | 9,407 | 9,920 | 10,321 | 7,398 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 181.4 | 183.7 | 128.36 | 134.9 | 118.6 | 84.6 |
Accrued Expenses | 117.1 | 137.6 | 87.69 | 100.08 | 116.03 | 97.5 |
Short-Term Debt | 826.32 | 176.93 | 137.45 | - | - | - |
Current Portion of Long-Term Debt | 396.03 | 112.26 | 56.35 | 1,256 | 1,197 | - |
Current Portion of Leases | 17.61 | 27.23 | 31.61 | 23.23 | 20.11 | 20.34 |
Current Income Taxes Payable | 15.6 | 11.88 | - | - | - | - |
Current Unearned Revenue | 34.05 | 105.43 | - | - | 12 | 19.48 |
Other Current Liabilities | 595.49 | 628.72 | 607.82 | 567.64 | 611.52 | 107.39 |
Total Current Liabilities | 2,184 | 1,384 | 1,049 | 2,082 | 2,075 | 329.3 |
Long-Term Debt | 981.5 | 1,276 | 1,322 | 331.88 | 287.76 | 1,238 |
Long-Term Leases | 11.58 | 19.03 | 27.44 | 43.65 | 35.44 | 47.44 |
Long-Term Unearned Revenue | 306.32 | 289.42 | 263 | 281.78 | 278.2 | 123.61 |
Long-Term Deferred Tax Liabilities | 48.23 | 106.51 | - | - | - | - |
Total Liabilities | 3,531 | 3,074 | 2,662 | 2,739 | 2,677 | 1,739 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Additional Paid-In Capital | 12,273 | 12,199 | 12,111 | 12,150 | 11,756 | 9,372 |
Retained Earnings | -4,631 | -4,878 | -5,520 | -5,080 | -4,423 | -3,536 |
Treasury Stock | -19.75 | -19.75 | -3.1 | - | - | - |
Comprehensive Income & Other | 48.76 | 425.12 | 137.99 | 77.23 | 263.73 | -230.85 |
Total Common Equity | 7,671 | 7,727 | 6,725 | 7,148 | 7,597 | 5,605 |
Minority Interest | 15.66 | 22.35 | 20.63 | 32.86 | 47.23 | 54.36 |
Shareholders' Equity | 7,687 | 7,749 | 6,746 | 7,181 | 7,644 | 5,659 |
Total Liabilities & Equity | 11,218 | 10,824 | 9,407 | 9,920 | 10,321 | 7,398 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,233 | 1,611 | 1,575 | 1,655 | 1,540 | 1,306 |
Net Cash (Debt) | 5,659 | 5,461 | 5,425 | 6,632 | 7,471 | 4,940 |
Net Cash Growth | 2.56% | 0.66% | -18.20% | -11.22% | 51.24% | 76.67% |
Net Cash Per Share | 3.11 | 3.23 | 3.20 | 3.89 | 5.05 | 3.62 |
Filing Date Shares Outstanding | 1,756 | 1,932 | 1,694 | 1,690 | 1,682 | 1,410 |
Total Common Shares Outstanding | 1,756 | 1,932 | 1,694 | 1,690 | 1,682 | 1,410 |
Working Capital | 7,019 | 6,678 | 6,771 | 6,683 | 7,224 | 6,088 |
Book Value Per Share | 4.37 | 4.00 | 3.97 | 4.23 | 4.52 | 3.98 |
Tangible Book Value | 7,425 | 7,476 | 6,464 | 6,879 | 7,553 | 5,567 |
Tangible Book Value Per Share | 4.23 | 3.87 | 3.81 | 4.07 | 4.49 | 3.95 |
Buildings | 425.03 | - | - | 364.63 | 224.41 | 81.04 |
Machinery | 419.29 | 405.49 | 362.86 | 302.01 | 248.13 | 127.57 |
Construction In Progress | 134.74 | 115.01 | 138.86 | 166.91 | 197.65 | 230.72 |
Leasehold Improvements | - | - | - | - | 35.44 | 6.68 |